Stoke Therapeutics (STOK) Institutional Ownership $19.56 -0.12 (-0.61%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$19.47 -0.09 (-0.46%) As of 08/22/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Stoke Therapeutics (NASDAQ:STOK)Number ofInstitutional Buyers(last 12 months)80TotalInstitutional Inflows(last 12 months)$170.05MNumber ofInstitutional Sellers(last 12 months)36TotalInstitutional Outflows(last 12 months)$140.39M Get STOK Insider Trade Alerts Want to know when executives and insiders are buying or selling Stoke Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data STOK Institutional Buying and Selling by Quarter Stoke Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 Tower Research Capital LLC TRC 4,370$50K0.0%+461.0%0.008% 8/15/2025 Corient Private Wealth LLC659,834$7.49M0.0%N/A1.204% 8/15/2025 Rafferty Asset Management LLC51,458$584K0.0%-16.6%0.094% 8/15/2025 Opaleye Management Inc.562,120$6.38M1.3%+87.4%1.026% 8/15/2025 Lazard Asset Management LLC13,832$156K0.0%N/A0.025% 8/15/2025 Gilder Gagnon Howe & Co. LLC129,571$1.47M0.0%+22.4%0.236% 8/15/2025 Engineers Gate Manager LP33,276$378K0.0%N/A0.061% 8/15/2025 BNP Paribas Financial Markets4,186$48K0.0%+66.2%0.008% 8/15/2025 Bank of America Corp DE548,090$6.22M0.0%+2.9%1.000% 8/14/2025 MPM Bioimpact LLC789,698$8.96M1.6%+13.8%1.441% Get the Latest News and Ratings for STOK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Stoke Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/14/2025 Jane Street Group LLC34,743$394K0.0%+28.8%0.064% 8/14/2025 Redmile Group LLC4,375,931$49.67M5.3%-2.5%8.015% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.53,411$607K0.0%+121.0%0.098% 8/14/2025 The Manufacturers Life Insurance Company 15,099$171K0.0%+14.1%0.028% 8/13/2025 Marshall Wace LLP2,300,554$26.11M0.0%+7.9%4.214% 8/13/2025 Invesco Ltd.40,207$456K0.0%+53.6%0.074% 8/13/2025 Virtus Investment Advisers LLC7,955$90K0.0%-40.3%0.015% 8/13/2025 Advantage Alpha Capital Partners LP17,888$203K0.1%N/A0.033% 8/13/2025 Kennondale Capital Management LLC61,183$694K0.7%+45.3%0.112% 8/12/2025 American Century Companies Inc.27,339$310K0.0%N/A0.050% 8/12/2025 Rhumbline Advisers66,419$754K0.0%+33.9%0.122% 8/12/2025 Franklin Resources Inc.81,395$924K0.0%+264.8%0.149% 8/12/2025 Legal & General Group Plc31,077$353K0.0%-12.1%0.057% 8/12/2025 JPMorgan Chase & Co.25,655$291K0.0%+26.6%0.047% 8/12/2025 Swiss National Bank62,000$704K0.0%-7.9%0.114% 8/11/2025 Integrated Quantitative Investments LLC19,300$219K0.1%N/A0.035% 8/8/2025 Intech Investment Management LLC18,217$207K0.0%-18.4%0.033% 8/8/2025 Creative Planning44,215$502K0.0%+251.0%0.081% 8/8/2025 Police & Firemen s Retirement System of New Jersey9,558$108K0.0%+33.2%0.018% 8/8/2025 Geode Capital Management LLC972,921$11.04M0.0%+7.9%1.782% 8/7/2025 Profund Advisors LLC10,986$125K0.0%-14.7%0.020% 8/7/2025Aviva PLC43,955$499K0.0%N/A0.081% 8/7/2025 Los Angeles Capital Management LLC19,715$224K0.0%N/A0.036% 7/31/2025 AlphaQuest LLC6,293$71K0.0%-41.9%0.012% 7/30/2025 Skorpios Trust3,256,181$36.96M99.6%-52.9%5.964% 7/25/2025 Allspring Global Investments Holdings LLC35,404$402K0.0%N/A0.065% 7/23/2025 KLP Kapitalforvaltning AS13,200$150K0.0%+131.6%0.024% 7/11/2025 Assenagon Asset Management S.A.537,973$6.11M0.0%-43.9%0.985% 5/23/2025 Siren L.L.C.2,247,347$14.95M0.9%+12.4%4.116% 5/19/2025 Jane Street Group LLC26,978$179K0.0%+125.2%0.049% Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.Click here to download the guide and protect your assets before Sept 15th.5/16/2025 Goldman Sachs Group Inc.1,662,039$11.05M0.0%+21.4%3.044% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,167$162K0.0%+5.0%0.044% 5/16/2025 Jacobs Levy Equity Management Inc.357,248$2.38M0.0%N/A0.654% 5/16/2025 Granahan Investment Management LLC660,430$4.39M0.2%+16.3%1.210% 5/16/2025 Checkpoint Capital L.P.730,717$4.86M2.7%+139.3%1.338% 5/16/2025 AQR Capital Management LLC12,847$85K0.0%-45.6%0.024% 5/16/2025 ADAR1 Capital Management LLC30,085$200K0.0%N/A0.055% 5/15/2025 Redmile Group LLC4,485,981$29.83M2.8%-2.3%8.217% 5/15/2025 MPM Bioimpact LLC693,988$4.62M0.8%+1.2%1.271% 5/15/2025 DAFNA Capital Management LLC443,998$2.95M0.8%+159.5%0.813% 5/15/2025 Siren L.L.C.2,247,347$14.95M0.9%+12.4%4.116% 5/15/2025 Trexquant Investment LP86,140$573K0.0%-16.4%0.158% 5/14/2025 Rafferty Asset Management LLC61,706$410K0.0%-8.2%0.113% 5/14/2025 AlphaQuest LLC10,832$72K0.0%N/A0.020% 5/14/2025 Erste Asset Management GmbH396,000$2.67M0.0%N/A0.725% 5/14/2025 Wellington Management Group LLP135,960$904K0.0%+0.9%0.249% 5/13/2025 Fox Run Management L.L.C.13,780$92K0.0%N/A0.025% 5/13/2025 Russell Investments Group Ltd.16,119$107K0.0%N/A0.030% 5/12/2025 Nuveen LLC108,087$719K0.0%N/A0.198% 5/12/2025 Invesco Ltd.26,183$174K0.0%+117.0%0.048% 5/9/2025 Deutsche Bank AG25,566$170K0.0%-92.7%0.047% 5/9/2025 Charles Schwab Investment Management Inc.310,307$2.06M0.0%-9.3%0.568% 5/9/2025 Vanguard Group Inc.2,784,202$18.52M0.0%+1.9%5.100% 5/8/2025 US Bancorp DE11,222$75K0.0%+9,743.9%0.021% 5/8/2025 XTX Topco Ltd40,181$267K0.0%N/A0.074% 5/7/2025 Dauntless Investment Group LLC28,600$190K0.2%N/A0.052% 5/6/2025 Kennondale Capital Management LLC42,100$280K0.3%N/A0.077% 4/30/2025 Alps Advisors Inc.39,890$265K0.0%-6.9%0.073% 4/29/2025 Bank of New York Mellon Corp89,985$598K0.0%-3.4%0.165% 4/15/2025 Net Worth Advisory Group20,741$138K0.0%N/A0.038% 4/15/2025 Assenagon Asset Management S.A.959,603$6.38M0.0%-29.0%1.774% 4/7/2025 GAMMA Investing LLC5,360$36K0.0%+1,842.0%0.010% 3/24/2025 Wellington Management Group LLP134,812$1.49M0.0%-1.6%0.249% 3/18/2025 California State Teachers Retirement System32,068$354K0.0%+16.2%0.061% 2/19/2025 Toronto Dominion Bank3,173,258$35.00M0.1%N/A5.991% 2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC95,505$1.05M0.0%+123.7%0.180% 2/17/2025 Voloridge Investment Management LLC86,888$958K0.0%-29.4%0.164% 2/17/2025 Squarepoint Ops LLC120,242$1.33M0.0%+6.7%0.227% 2/17/2025 Two Sigma Investments LP53,950$595K0.0%-53.8%0.102% 2/17/2025 Tang Capital Management LLC300,000$3.31M0.2%N/A0.566% 2/17/2025 Toronto Dominion Bank3,173,258$35.00M0.1%N/A5.991% 2/17/2025 RTW Investments LP5,123,525$56.51M0.9%+10.1%9.673% 2/17/2025 Rafferty Asset Management LLC67,227$742K0.0%-18.8%0.127% 2/17/2025 Redmile Group LLC4,593,629$50.67M3.5%-2.5%8.672% 2/17/2025 ProShare Advisors LLC12,626$139K0.0%N/A0.024% 2/17/2025 MPM Bioimpact LLC685,826$7.57M1.1%+43.0%1.295% 2/17/2025 Millennium Management LLC76,829$847K0.0%+417.9%0.145% 2/17/2025 Group One Trading LLC104,411$1.15M0.0%+2.8%0.197% 2/17/2025 Graham Capital Management L.P.18,634$206K0.0%+8.5%0.035% 2/17/2025 Granahan Investment Management LLC567,689$6.26M0.3%-12.0%1.072% Tax Drain Deadline: Protect Your Wealth Before September 15th (Ad)On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.Click here to download the guide and protect your assets before Sept 15th.2/17/2025 D. E. Shaw & Co. Inc.28,043$309K0.0%-83.6%0.053% 2/17/2025 Deutsche Bank AG350,614$3.87M0.0%-24.2%0.662% 2/17/2025 DAFNA Capital Management LLC171,097$1.89M0.5%-17.5%0.323% 2/17/2025 Baker BROS. Advisors LP4,633,838$51.11M0.5%+6.1%8.748% 2/17/2025 Bank of America Corp DE9,091$100K0.0%-92.7%0.017% 2/17/2025 BNP Paribas Financial Markets4,422$49K0.0%-94.2%0.008% 2/17/2025 Ameriprise Financial Inc.10,527$116K0.0%-26.5%0.020% 2/14/2025 Jane Street Group LLC11,977$132K0.0%-96.4%0.023% 2/14/2025 Freestone Grove Partners LP18,049$199K0.0%N/A0.034% 2/14/2025 Schonfeld Strategic Advisors LLC291,795$3.22M0.0%N/A0.551% (Data available from 1/1/2016 forward) STOK Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of STOK shares? During the previous two years, 120 institutional investors and hedge funds held shares of Stoke Therapeutics. The most heavily invested institutionals were Lynx1 Capital Management LP ($70.05M), RTW Investments LP ($56.51M), Baker BROS. Advisors LP ($51.11M), Redmile Group LLC ($49.67M), Skorpios Trust ($36.96M), Toronto Dominion Bank ($35.00M), and Marshall Wace LLP ($26.11M).Learn more on Stoke Therapeutics' institutional investors. Which institutional investors have been buying Stoke Therapeutics' stock? Of the 100 institutional investors that purchased Stoke Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Toronto Dominion Bank ($6.35M), Lynx1 Capital Management LP ($3.94M), Redmile Group LLC ($2.45M), Baker BROS. Advisors LP ($1.60M), Assenagon Asset Management S.A. ($1.51M), Marshall Wace LLP ($1.15M), and Healthcare of Ontario Pension Plan Trust Fund ($1.15M). How much institutional buying is happening at Stoke Therapeutics? Institutional investors have bought a total of 16,037,431 shares in the last 24 months. This purchase volume represents approximately $170.05M in transactions. Which of Stoke Therapeutics' major shareholders have been selling company stock? Of the 36 institutional investors that sold Stoke Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Skorpios Trust ($7.59M), Franklin Resources Inc. ($1.19M), Assenagon Asset Management S.A. ($968.68K), Marshall Wace LLP ($719.30K), Deutsche Bank AG ($436.91K), Redmile Group LLC ($345.12K), and Jane Street Group LLC ($318.47K). How much institutional selling is happening at Stoke Therapeutics? Institutional investors have sold a total of 12,564,052 shares in the last 24 months. This volume of shares sold represents approximately $140.39M in transactions. Related Companies ZLAB Major Shareholders AKRO Major Shareholders TLX Major Shareholders PTCT Major Shareholders LNTH Major Shareholders APLS Major Shareholders MLTX Major Shareholders PTGX Major Shareholders MIRM Major Shareholders MTSR Major Shareholders This page (NASDAQ:STOK) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access